381
Participants
Start Date
March 10, 2022
Primary Completion Date
November 28, 2022
Study Completion Date
November 28, 2022
Enclitide Chloride
Enclitide Chloride administered orally
Placebo
Placebo matching enclitide chloride administered orally
Akershus Universitetssykehus-Hjertemedisinsk Avdeling ( Site 0705), Lørenskog
Sykehuset i Vestfold-Hjerteseksjonen ( Site 0703), Tønsberg
Stavanger Universitetssykehus ( Site 0706), Stavanger
Nordlandssykehuset ( Site 0709), Bodø
Bio Investigación AMARC, S.C. ( Site 0204), Mexico City
Hospital Angeles Mocel ( Site 0209), Mexico City
Mid Hudson Medical Research ( Site 0004), New Windsor
Charité Campus Virchow-Klinikum ( Site 0505), Berlin
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0212), Mexico City
altoona center for clinical research ( Site 0045), Duncansville
Centro de Atención e Investigación Clínica ( Site 0214), Aguascalientes
National Clinical Research, Inc-research office ( Site 0019), Richmond
Eskisehir Osmangazi University-Cardiology ( Site 1000), Eskişehir
Piedmont Research Partners ( Site 0005), Fort Mill
Alliance for Multispecialty Research, LLC ( Site 0050), Coral Gables
Excel Medical Clinical Trials ( Site 0042), Boca Raton
ForCare Clinical Research ( Site 0017), Tampa
Ambulantes Herzzentrum Kassel ( Site 0501), Kassel
Ege University Medicine of Faculty-Cardilogy Department ( Site 1003), Bornova
The University of Mississippi Medical Center-Clinical Research and Trials Unit ( Site 0028), Jackson
L-MARC Research Center ( Site 0003), Louisville
Keimyung University Dongsan Hospital ( Site 1703), Daegu
Unidad de Investigaci�n Cl�nica Cardiometabolica de Occident-Unidad de Investigación Clínica Cardio, Guadalajara
Midwest Institute For Clinical Research ( Site 0036), Indianapolis
Healthcare Research Network - Chicago ( Site 0037), Flossmoor
Unidad biomedica avanzada monterrey-Clinical Trials ( Site 0200), Monterrey
Cotton O'Neil Mulvane ( Site 0022), Topeka
Dallas Diabetes Research Center ( Site 0012), Dallas
Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0051), Houston
Northeast Clinical Research of San Antonio ( Site 0014), San Antonio
Klinikum der Ludwig-Maximilians-Universitaet Muenchen ( Site 0504), München
New Mexico Clinical Research & Osteoporosis Center ( Site 0032), Albuquerque
Jubilee Clinical Research ( Site 0047), Las Vegas
Centro de Estudios de Investigacion Metabolicos y Cardiovasculares-Subinvestigation ( Site 0201), Ciudad Madero
Westside Medical Associates of Los Angeles ( Site 0026), Beverly Hills
Kardiologische Gemeinschaftspraxis ( Site 0502), Nuremberg
Hospital Angeles Xalapa-Internal Medicine-Cardiology ( Site 0202), Xalapa
National Research Institute (NRI) - Santa Ana ( Site 0024), Santa Ana
Clinical Trials Research ( Site 0007), Sacramento
Medical Care and Research SA de CV ( Site 0211), Mérida
Universitätsklinikum Leipzig ( Site 0500), Leipzig
Chubu Rosal Hospital ( Site 1612), Nagoya
Kyoto Okamoto Memorial Hospital ( Site 1611), Kuse-gun Kumiyama-cho
Kitada Clinic ( Site 1604), Osaka
Medical Corporation Heishinkai OCROM Clinic ( Site 1600), Suita-shi
Seiwa Clinic ( Site 1605), Adachi-ku
meiwa hospital ( Site 1602), Chiyoda-ku
Heishinkai Medical Group ToCROM Clinic ( Site 1601), Shinjuku-ku
Sekino Hospital ( Site 1603), Toshimaku
Instituto Jalisciense de Investigacion en Diabetes y Obesidad-Endocrinology ( Site 0205), Guadalajara
Oslo Universitetssykehus Aker-Preventiv kardiologi Aker ( Site 0704), Oslo
Oslo Universitetssykehus Rikshospitalet-Kardiologisk avdeling ( Site 0702), Oslo
Oslo Universitetssykehus Ullevål-Hjertemedisinsk avdeling, Ullevål ( Site 0701), Oslo
Oslo Universitetssykehus Aker-Lipidklinikken ( Site 0700), Oslo
Seoul National University Hospital ( Site 1702), Seoul
Severance Hospital, Yonsei University Health System ( Site 1701), Seoul
Samsung Medical Center ( Site 1700), Seoul
Hacettepe Universitesi ( Site 1002), Ankara
Royal Free Hospital ( Site 1311), London
Queen Elizabeth University Hospital-Glasgow Clinical Research Facility ( Site 1310), Glasgow
Layton Medical Centre ( Site 1303), Blackpool
William Harvey Heart Centre ( Site 1308), London
Walsall Manor Hospital ( Site 1309), West Midlands
Merck Sharp & Dohme LLC
INDUSTRY